- Home
- KMDA vs BNTC Comparison
KMDA vs BNTC Comparison
Compare KMDA & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- BNTC
- Stock Information
- Founded
- KMDA 1990
- BNTC 1995
- Country
- KMDA Israel
- BNTC United States
- Employees
- KMDA N/A
- BNTC N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- KMDA Health Care
- BNTC Health Care
- Exchange
- KMDA Nasdaq
- BNTC Nasdaq
- Market Cap
- KMDA 398.5M
- BNTC 365.1M
- IPO Year
- KMDA N/A
- BNTC N/A
- Fundamental
- Price
- KMDA $6.95
- BNTC $16.17
- Analyst Decision
- KMDA Strong Buy
- BNTC Strong Buy
- Analyst Count
- KMDA 2
- BNTC 5
- Target Price
- KMDA $13.00
- BNTC $24.80
- AVG Volume (30 Days)
- KMDA 77.7K
- BNTC 62.8K
- Earning Date
- KMDA 11-12-2025
- BNTC 11-13-2025
- Dividend Yield
- KMDA 2.88%
- BNTC N/A
- EPS Growth
- KMDA 27.97
- BNTC N/A
- EPS
- KMDA 0.32
- BNTC N/A
- Revenue
- KMDA $169,517,000.00
- BNTC N/A
- Revenue This Year
- KMDA $14.49
- BNTC N/A
- Revenue Next Year
- KMDA $10.12
- BNTC N/A
- P/E Ratio
- KMDA $21.01
- BNTC N/A
- Revenue Growth
- KMDA 9.67
- BNTC N/A
- 52 Week Low
- KMDA $5.43
- BNTC $9.10
- 52 Week High
- KMDA $9.16
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- KMDA 52.44
- BNTC 62.96
- Support Level
- KMDA $6.72
- BNTC $15.18
- Resistance Level
- KMDA $7.11
- BNTC $16.76
- Average True Range (ATR)
- KMDA 0.19
- BNTC 0.84
- MACD
- KMDA 0.03
- BNTC 0.06
- Stochastic Oscillator
- KMDA 60.68
- BNTC 79.44
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.